Atwood & Palmer’s Nutex Health NUTX Stock Holding History

Atwood & Palmer’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13	Closed	-$1.34K	–	496
2025 Q3	$1.34K	Hold	13	–	–	﹤0.01%	454
2025 Q2	$1.62K	Hold	13	–	–	﹤0.01%	473
2025 Q1	$612	Hold	13	–	–	﹤0.01%	421
2024 Q4	$412	Hold	13	–	–	﹤0.01%	453
2024 Q3	$283	Hold	13	–	–	﹤0.01%	458
2024 Q2	$80	Hold	13	–	–	﹤0.01%	431
2024 Q1	$192	Hold	13	–	–	﹤0.01%	405
2023 Q4	$360	Buy	+13	New	+$405	﹤0.01%	390

Other funds holding NUTX

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Atwood & Palmer's NUTX Position: Q4 2025 in Review

Atwood & Palmer sold out of Nutex Health (NUTX) in Q4 2025, closing a stake of 13 shares — an estimated $1.34K sold.

Atwood & Palmer first reported a position in NUTX in Q4 2023 and held it in 8 quarters. The position peaked at $1.62K in Q2 2025. 117 funds tracked by Wall St. Rank hold NUTX as of Q4 2025.

Atwood & Palmer reported no remaining Nutex Health position as of Q4 2025 after selling out during the quarter.
Atwood & Palmer sold 13 Nutex Health shares in Q4 2025, an estimated $1.34K.
Atwood & Palmer first reported a position in Nutex Health in Q4 2023 and held it in 8 quarters.
Atwood & Palmer's Nutex Health position peaked at $1.62K in Q2 2025.
117 funds tracked by Wall St. Rank held Nutex Health as of Q4 2025.

Based on Atwood & Palmer's 13F filing for Q4 2025, filed 28 Jan 2026.